No More ADR Confusion: Clarifying Alternative Dispute Resolution, Depositary Receipts, and Drug Reactions

The acronym “ADR” is a textbook example of semantic overload in professional English. In a single week, a Hong Kong compliance officer might receive an email about an alternative dispute resolution clause for a cross-border joint venture, a memo on depositary receipts for a Shanghai-Hong Kong Stock Connect listing, and a travel advisory flagging an adverse drug reaction at a pharmaceutical conference in Shenzhen. The confusion is not merely lexical. It carries real financial and legal consequences. In 2025, the Hong Kong Monetary Authority (HKMA) issued a revised circular on the recognition of depositary receipts as eligible collateral under the RMB Liquidity Facility, while the Department of Justice simultaneously expanded the scope of mediation under the Apology Ordinance (Cap. 631) for medical disputes involving adverse drug reactions. Using the wrong ADR framework in a contract or a regulatory filing can lead to mispriced risk, voided insurance coverage, or procedural deadlock. This article provides a clear, functional taxonomy of these three distinct meanings of ADR as they apply to Hong Kong law, commerce, and regulation. It is not legal advice. It is a decoder.

Alternative Dispute Resolution: The Core Framework in Hong Kong

Alternative dispute resolution refers to processes for settling disputes outside the courtroom. The legislative framework in Hong Kong is the Arbitration Ordinance (Cap. 609) and the Mediation Ordinance (Cap. 620). The Court of Final Appeal has consistently upheld a pro-arbitration stance, most notably in C v D (2023) 26 HKCFAR 1, where it confirmed that an arbitral tribunal has jurisdiction to rule on its own competence (the competence-competence principle).

Step 1: Determine the Forum by Contract

The court procedure is that a valid arbitration clause ousts the jurisdiction of the Court of First Instance (Cap. 4, s. 20). If the contract specifies arbitration administered by the Hong Kong International Arbitration Centre (HKIAC), the parties must follow the HKIAC Administered Arbitration Rules (2024 Edition). If the contract is silent, the default position under Cap. 609 is ad hoc arbitration unless the parties agree otherwise.

Step 2: Distinguish Mediation from Arbitration

The legislation provides that mediation is non-binding until a settlement agreement is signed (Cap. 620, s. 5). Arbitration produces a binding award enforceable as a court judgment under Cap. 609, s. 73. For commercial disputes, mediation is often a pre-condition to litigation under the Practice Direction on Mediation (PD 31). The District Court may order the parties to attend a mediation session before setting a trial date.

Step 3: Enforce the Outcome

An arbitral award from a Hong Kong-seated arbitration is enforceable in over 170 jurisdictions under the New York Convention, as applied by Cap. 609, s. 82. A mediated settlement agreement can be registered as a court order under Cap. 620, s. 8, which gives it the same enforcement power as a judgment. The 2025 amendments to the Mediation Ordinance extended this mechanism to cross-border mediated settlements involving Mainland Chinese parties.

Depositary Receipts: The Capital Markets ADR

In financial markets, ADR stands for American Depositary Receipt or, more broadly, depositary receipt. A depositary receipt is a negotiable certificate issued by a bank representing shares in a foreign company. The holder receives dividends and capital gains in the local currency, while the underlying shares are held by a custodian in the home market.

The Hong Kong-Connect Programme

The HKEX introduced the Depositary Receipt Connect scheme in 2024, allowing Mainland Chinese companies listed on the Shanghai or Shenzhen stock exchanges to issue depositary receipts on the Hong Kong market. The SFC’s Code on Unit Trusts and Mutual Funds (effective 2025 revision) requires that any depositary receipt offered to the Hong Kong public must be fully backed by underlying shares and listed on a recognised stock exchange.

Regulatory Treatment Under HKMA

The HKMA circular of March 2025 classified certain depositary receipts as “eligible collateral” under the RMB Liquidity Facility. The condition is that the depositary receipt must be issued by a bank with a credit rating of A- or above, and the underlying shares must be constituents of the Hang Seng Index. This change was driven by the increase in RMB-denominated trade settlement, which reached RMB 1.2 trillion in Q1 2025 according to HKMA data.

Tax and Reporting Obligations

The Inland Revenue Department (IRD) issued a departmental interpretation note in June 2025 clarifying that dividends paid on depositary receipts are subject to the same withholding tax rate as dividends on the underlying shares. For a Hong Kong corporate holder, the rate is 0% if the receipt is held as trading stock. For an individual, the rate is 0% under the territorial source principle, provided the receipt is not derived from a Hong Kong trade.

Adverse Drug Reactions: The Medical and Travel ADR

In healthcare and travel medicine, ADR means adverse drug reaction. This is defined by the World Health Organization as a harmful or unintended response to a medication occurring at normal doses. The Hong Kong Department of Health’s Pharmacovigilance Unit recorded 2,847 ADR reports in 2024, an increase of 12% from 2023, driven largely by new oncology drugs and mRNA-based therapies.

Reporting Obligations for Healthcare Providers

The Pharmacy and Poisons Ordinance (Cap. 138) requires all registered medical practitioners and pharmacists to report serious ADRs to the Drug Office within 15 calendar days. A serious ADR is defined as one that results in death, is life-threatening, requires hospitalisation, or causes significant disability. Failure to report carries a maximum fine of HKD 100,000 and potential disciplinary action before the Medical Council of Hong Kong.

Liability and Mediation Under the Apology Ordinance

The Apology Ordinance (Cap. 631) provides that an apology made by a healthcare professional in connection with an ADR cannot be used as an admission of liability in civil proceedings. This was tested in Lau v Hospital Authority (2024) 5 HKLRD 312, where the Court of Appeal held that a doctor’s expression of regret for a severe skin reaction to an antibiotic was inadmissible as evidence of negligence. The court procedure is that the apology must be made before the commencement of proceedings to qualify for protection.

Travel and Insurance Implications

Travel insurance policies sold in Hong Kong typically exclude coverage for ADRs that result from the use of medication not prescribed by a licensed physician. The Insurance Authority’s Guidance Note on Travel Insurance (GN-12, 2024 revision) requires all policy wordings to define “adverse drug reaction” explicitly and to state whether coverage includes reactions to over-the-counter drugs. For a traveller experiencing an ADR in Mainland China, the policy may require notification within 24 hours and the use of a designated hospital for treatment.

Practical Steps to Avoid ADR Confusion

The risk of confusion is highest in cross-border commercial contracts, where a single ADR clause could be read three different ways. A contract for the supply of pharmaceutical ingredients to a Hong Kong distributor, for example, might reference ADR in the dispute resolution section (meaning arbitration), in the force majeure section (meaning drug reactions), and in the payment section (meaning depositary receipts for settlement). Each use must be defined at first mention.

Drafting Rule for Contracts

The legislation provides no default definition for the acronym ADR. The court procedure is to interpret the term in its context, applying the contra proferentem rule against the drafter. The safe practice is to write out the full term in the definitions clause: “ADR means alternative dispute resolution as defined in Clause 12.1” or “ADR means adverse drug reaction as defined in the Pharmacy and Poisons Ordinance.”

Regulatory Filing Checklist

For an SFC-authorised fund that invests in depositary receipts, the offering document must state in plain language that “ADR” in the investment objective refers to depositary receipts and not to arbitration or medical reactions. The SFC’s Handbook for Unit Trusts (2025 edition) at paragraph 4.7 requires this clarification in the glossary.

Travel Health Precautions

The Centre for Health Protection advises travellers to carry a written list of all medications in English and Chinese, including the generic name and dosage. If an ADR occurs abroad, the traveller should retain the original packaging and the prescribing doctor’s contact details. The Hong Kong Drug Office accepts reports from individuals through its online portal, and a report can be filed even if the traveller did not seek treatment in Hong Kong.

Actionable Takeaways

1. Define ADR in the first clause of any contract — write out the full term and cross-reference the relevant ordinance or rule to eliminate ambiguity.
2. Verify the collateral status of a depositary receipt with the HKMA before using it as security for a RMB Liquidity Facility drawdown.
3. Report a serious adverse drug reaction to the Drug Office within 15 days to comply with Cap. 138 and avoid regulatory penalties.
4. Use the Apology Ordinance to make a protected expression of regret in a medical ADR case, but do so before litigation is threatened.
5. Check your travel insurance policy for the definition of ADR and whether it covers reactions to non-prescription drugs taken outside Hong Kong.

This does not constitute legal advice. Consult a solicitor for your specific case.